Cantor Fitzgerald Maintains Neutral on Aleafia Health, Lowers Price Target to C$0.5
Cantor Fitzgerald analyst Pablo Zuanic maintains Aleafia Health (TSX:AH) with a Neutral and lowers the price target from C$0.55 to C$0.5.
The Week In Cannabis: Trulieve’s $2.1B Acquisition, New ETF, Earnings, Federal Legalization And More
In a week of big M&A news and mixed earnings reports, cannabis stocks traded mostly down.